Page last updated: 2024-10-19
phenol and Injuries, Knee
phenol has been researched along with Injuries, Knee in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Fullerton, BD | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Rotator Cuff Tendinopathy: A Randomized and Blinded Comparison of Superficial and Deep Injection Methods[NCT01402011] | | 77 participants (Actual) | Interventional | 2010-11-30 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Change From Baseline in Maximum Pain Score at 9 Months
Participants were asked about pain at rest, at work, doing sports. The maximum pain reported on a scale ranging from 0 (no pain at all) to 10 (extreme pain) was recorded for each participant. Maximum of pain scores rest, work, sport recorded. Calculated as pain at baseline - pain at 9 months. (NCT01402011)
Timeframe: baseline and 9 months
| Intervention | units on a scale (Mean) |
|---|
| 25% Dextrose in Ligaments and Tendons | 2.9 |
| .1% Lidocaine in Ligaments and Tendons | 1.8 |
| .1% Lidocaine Subcutaneous | 1.3 |
Change From Baseline of Visual Analog Pain Scale at 3 Months
Subject marks his pain level at rest, at work, doing sports on a 10 cm scale. Maximum of pain scores rest, work, sport recorded. Calculated as pain at baseline - pain at 3 months. VAS scale is from 0 = no pain to 10 = maximum pain (NCT01402011)
Timeframe: baseline and three months
| Intervention | units on a scale (Mean) |
|---|
| 25% Dextrose in Ligaments and Tendons | 3.0 |
| .1% Lidocaine in Ligaments and Tendons | 2.7 |
| .1% Lidocaine Subcutaneous | 2.7 |
Nine Month Satisfaction Questionnaire
Phone call asking how satisfied were they with their treatment 10 = extremely satisfied, 0 = extremely dissatisfied ) (NCT01402011)
Timeframe: Nine months after first injection treatment appointment
| Intervention | units on a scale (Mean) |
|---|
| 25% Dextrose in Ligaments and Tendons | 6.7 |
| .1% Lidocaine in Ligaments and Tendons | 4.7 |
| .1% Lidocaine Subcutaneous | 3.9 |
Visual Analog Pain Scale 0= no Pain 10 = Maximum Pain
Subject marks his pain level at rest, at work, doing sports on a 10 cm scale. The maximum pain level among the 3 different activities was recorded. (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit
| Intervention | units on a scale (Mean) |
|---|
| 25% Dextrose in Shoulder Entheses | 7.3 |
| .1% Lidocaine in Shoulder Entheses | 6.9 |
| .1% Lidocaine Subcu. Above Shouldr Enth. | 6.9 |
Disabilities of the Arm Shoulder and Hand Questionnaire
http://www.dash.iwh.on.ca/assets/images/pdfs/DASH_quest06.pdf 30 questions assessing ability to use shoulder in everyday activities, each question scored 1 to 5, where one is normal, no problem and five is unable to perform. No data was collected at 9 months. The score ranges from 30 to 150. Higher scores represent worse outcomes. (NCT01402011)
Timeframe: 20 minutes before the first injection and at 3 months
| Intervention | units on a scale (Mean) |
|---|
| Baseline | 3 months |
|---|
| .1% Lidocaine in Ligaments and Tendons | 71.3 | 54.7 |
,| .1% Lidocaine Subcutaneous | 69.6 | 61 |
,| 25% Dextrose in Ligaments and Tendons | 72.4 | 61.3 |
Physical Examination of the Shoulder Scale
From Steven W. Brose, DO, Michael L. Boninger, MD, Bradley Fullerton, MD, Thane McCann, MD, From: Jennifer L. Collinger, BSE, Bradley G. Impink, BSE, Trevor A. Dyson-Hudson, MD Shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury. Arch Phys Med Rehabil 2008 Nov; 89:2086-93, appendix 1 12 parameters of shoulder examination: Biceps tendon/bicipital groove tenderness, Supraspinatus tendon/greater tuberosity tenderness Acromioclavicular joint tenderness Resisted external rotation. Resisted internal rotation. Supraspinatus test. Painful Arc Test. Neer impingement sign. Hawkins-Kennedy impingement sign. O'Brien Active Compression Test for AC Joint Pathology O'Brien Active Compression Test for Labral Pathology impingement sign. each test scored 0 = no pain, 1 = tenderness, 2 = pain. All 12 scores added. Range 0-24. Higher scores = more pathology (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit and at 3 months
| Intervention | units on a scale (Mean) |
|---|
| Baseline | 3 months |
|---|
| .1% Lidocaine in Ligaments and Tendons | 13.1 | 10.7 |
,| .1% Lidocaine Subcutaneous | 13 | 12.9 |
,| 25% Dextrose in Ligaments and Tendons | 13.2 | 11.4 |
Rotator Cuff Ultrasound, Ultrasound Shoulder Pathology Rating Scale
"From Brose et al. shoulder ultrasound abnormalities, physical examination findings, and pain in manual wheelchair users with spinal cord injury Arch Phys Med Rehabil 2008 Nov, 89: 2086-93 appendix 2. rates biceps tendinopathy (0-6), supraspinatus tendinopathy (0-5), greater tuberosity the cortical surface (0-3), dynamics supraspinatus impingement (0-3), dynamic subscapularis/ biceps/ coracoid impingement (0-3). The total score ranged from 0 to 20 with higher scores indicating a worse outcome. The change was calculated by taking the final score - the baseline score." (NCT01402011)
Timeframe: 20 minutes before first injection on first day of patient visit and at on average 9.4 months
| Intervention | units on a scale (Mean) |
|---|
| Baseline | change at 9.4 +/- 2.2 months |
|---|
| .1% Lidocaine in Ligaments and Tendons | 4.3 | -0.6 |
,| .1% Lidocaine Subcutaneous | 4.3 | -0.6 |
,| 25% Dextrose in Ligaments and Tendons | 4.0 | -0.3 |
Other Studies
1 other study available for phenol and Injuries, Knee